In metabolic disorders such as obesity and diabetes, individuals often exhibit reduced surface insulin receptor (INSR) content and diminished INSR kinase (IRK) activity, which are essential for proper insulin signaling [82]. This evidence concerns the gene INSR and obesity due to melanocortin 4 receptor deficiency.